Insider trades
Christopher Martell, Director of Candel Therapeutics CADL, has filed 2 purchases and 0 sales on the open market. The latest trade was on 06/23.
Christopher Martell
Director
- Company
- Candel Therapeutics CADL
- First filing
- 23/02/17
- Trades
- 7 trades
- Buys / sales
- 2 / 0
- 12-month net buying
- No record
- Last trade
- 06/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CADL | Open-market buyAmendment | 22/12/08–22/12/09 | 23/02/17 | 27,000 sh2 trades | $1.89avg. | $51,108 | +21.6% |